ACE-inhibitors: panacea for progressive renal disease?
- 1 June 1997
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 349 (9069), 1852-1853
- https://doi.org/10.1016/s0140-6736(97)22026-x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up studyBMJ, 1996
- Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal InsufficiencyNew England Journal of Medicine, 1996
- Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapyThe Lancet, 1996
- Randomised controlled trial of enalapril and blockers in non- diabetic chronic renal failureBMJ, 1994
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Long-Term Benefits of the Antiproteinuric Effect of Angiotensin-Converting Enzyme Inhibition in Nondiabetic Renal DiseaseAmerican Journal of Kidney Diseases, 1993
- NATURAL HISTORY OF BRIGHT'S DISEASE: CLINICAL, HISTOLOGICAL AND EXPERIMENTAL OBSERVATIONSThe Lancet, 1942